奥美医疗
(002950)
| 流通市值：36.69亿 | | | 总市值：54.08亿 |
| 流通股本：4.30亿 | | | 总股本：6.33亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 1,838,536,273.96 | 896,090,731.55 | 3,671,573,075.99 | 2,596,602,769 |
| 营业总成本 | 1,615,548,307.43 | 774,307,960.81 | 3,139,508,558.37 | 2,188,956,656.67 |
| 其他经营收益 | | | | |
| 营业利润 | 236,640,525.41 | 132,706,999.06 | 319,723,855.82 | 428,600,171.68 |
| 利润总额 | 235,767,102.46 | 131,645,701.13 | 309,015,546.02 | 427,929,956.38 |
| 净利润 | 205,089,211.02 | 113,286,393.61 | 257,146,067.18 | 354,886,223.32 |
| 每股收益 | | | | |
| 其他综合收益 | -5,548,921.33 | -6,489,607.78 | -2,601,690.95 | 651,981.93 |
| 综合收益总额 | 199,540,289.69 | 106,796,785.83 | 254,544,376.23 | 355,538,205.25 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 2,267,256,635.19 | 2,342,268,169.08 | 2,404,962,644.11 | 2,196,817,121.6 |
| 非流动资产: | | | | |
| 非流动资产合计 | 3,876,659,168.98 | 3,561,036,907.33 | 3,202,249,128.24 | 3,156,472,700.72 |
| 资产总计 | 6,143,915,804.17 | 5,903,305,076.41 | 5,607,211,772.35 | 5,353,289,822.32 |
| 流动负债: | | | | |
| 流动负债合计 | 1,423,104,693.6 | 1,269,365,101.29 | 1,329,257,042.12 | 1,096,260,299.22 |
| 非流动负债: | | | | |
| 非流动负债合计 | 996,293,060.35 | 912,311,321.22 | 663,122,862.16 | 508,466,641.3 |
| 负债合计 | 2,419,397,753.95 | 2,181,676,422.51 | 1,992,379,904.28 | 1,604,726,940.52 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 3,693,175,619.29 | 3,697,519,918.97 | 3,595,058,487.63 | 3,730,969,689.79 |
| 股东权益合计 | 3,724,518,050.22 | 3,721,628,653.9 | 3,614,831,868.07 | 3,748,562,881.8 |
| 负债和股东权益合计 | 6,143,915,804.17 | 5,903,305,076.41 | 5,607,211,772.35 | 5,353,289,822.32 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 1,915,569,448.58 | 1,001,488,559.1 | 3,914,404,123.28 | 2,865,784,737.13 |
| 经营活动现金流出小计 | 1,956,467,288.7 | 958,602,750.46 | 3,197,271,091.14 | 2,314,468,037 |
| 经营活动产生的现金流量净额 | -40,897,840.12 | 42,885,808.64 | 717,133,032.14 | 551,316,700.13 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 906,340,879.53 | 97,604,568.73 | 1,184,173,530.14 | 939,712,590.74 |
| 投资活动现金流出小计 | 1,722,225,996.76 | 738,540,340.94 | 1,450,267,296.16 | 1,149,338,758.58 |
| 投资活动产生的现金流量净额 | -815,885,117.23 | -640,935,772.21 | -266,093,766.02 | -209,626,167.84 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 779,126,618.97 | 326,110,000 | 869,262,421.16 | 554,882,951.15 |
| 筹资活动现金流出小计 | 520,191,351.09 | 169,488,124.37 | 934,436,945.01 | 818,264,715.77 |
| 筹资活动产生的现金流量净额 | 258,935,267.88 | 156,621,875.63 | -65,174,523.85 | -263,381,764.62 |
| 汇率变动对现金及现金等价物的影响 | -12,153,171.35 | -8,125,925.2 | -528,552.14 | 4,287,137.27 |
| 现金及现金等价物净增加额 | -610,000,860.82 | -449,554,013.14 | 385,336,190.13 | 82,595,904.94 |
| 期末现金及现金等价物余额 | 355,717,858.03 | 516,164,705.71 | 965,718,718.85 | 662,978,433.66 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -610,000,860.82 | - | 385,336,190.13 | - |